Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 10:21 pm
Share
Manhattan Scientifics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.009 million. Net loss was USD 0.071 million compared to USD 1.16 million a year ago.
For the nine months, sales was USD 0.05 million compared to USD 0.05 million a year ago. Net loss was USD 2.33 million compared to USD 3.61 million a year ago.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
MANHATTAN SCIENTIFICS, INC. 
